COMMUNIQUÉS West-GlobeNewswire

EMA Grants Orphan Medicinal Product Designation for Retrotope’s RT001 in the Treatment of Infantile Neuroaxonal Dystrophy (INAD), a PLA2G6 associated neurodegeneration (PLAN)
13/03/2019
LOS ALTOS, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Retrotope received notification from the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) that its request for orphan medicinal product [...]
NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)
13/03/2019
The shareholders of Active Biotech AB (publ) are invited to the Extraordinary Shareholders' Meeting to be held on Thursday April 4, 2019, at 5.00 pm in the Company's offices, Scheelevägen 22 in Lund, Sweden. ENTITLEMENT [...]
Active Biotech has entered into an agreement regarding sale of the Company's property - extraordinary general meeting on April 4, 2019
13/03/2019
Lund Sweden, March 13 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that Active Biotech has entered into an agreement regarding sale of the Company's property Forskaren 1 in Lund, Sweden, with a newly formed [...]
Media Advisory: 6th Canadian Obesity Summit
13/03/2019
OTTAWA, March 13, 2019 (GLOBE NEWSWIRE) -- ATTENTION: Editors/journalists covering health, wellness, nutrition, exercise, healthcare, bariatrics, obesity, social justice, social equity, research, and science. WHAT: 6th [...]
Annual General Meeting in ALK-Abelló A/S held on 13 March 2019
13/03/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) held its annual general meeting on 13 March 2019. The annual general meeting transacted the following business: Adoption of the annual report 2018 and discharge of the Board [...]
CORRECTING and REPLACING -- Acer Therapeutics to Participate in Upcoming Investor Conferences
13/03/2019
In a release issued earlier today by Acer Therapeutics Inc. (Nasdaq: ACER), please note in the table for the Roth Capital Partners 31 st Annual Growth Stock Conference, a time of 3:30 pm Pacific Time has been added for [...]
New study finds significant differences in how various adaptive servo ventilation (ASV) devices treat complex sleep apnea
13/03/2019
March 13, 2019 Using Philips PAP solutions, results resurface conversation around ASV therapy use for complex sleep apnea and its potential to improve quality of life Amsterdam, the Netherlands – Royal Philips (NYSE: [...]
Align Technology Showcases SmileView – an Online Tool for Prospective Invisalign Patients at 2019 International Dental Show
13/03/2019
SmileView Tool Helps People Visualize Their Straighter Smile Before They Start an Invisalign treatment COLOGNE, Germany and SAN JOSE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) [...]
PotNetwork Magazine Goes Out To Thousands of Cannabis Industry Investors
13/03/2019
Cannabis executives and entrepreneurs flock to the inaugural print issue from the sector's number one news site MIAMI, March 13, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Interest in PotNetwork Magazine is surging, as [...]
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
13/03/2019
HASBROUCK HEIGHTS, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the new appointment of Russell I. Thomson PhD, FRSC, as the Company's Director of [...]
Hemispherx Biopharma Announces Significant Progress in its Ampligen Pancreatic Cancer Program and Multiple Ampligen+Checkpoint Blockade Immuno-Oncology Programs
13/03/2019
Hemispherx Provides Quarterly Summary of Rapidly Advancing Oncology Clinical Programs OCALA, Fla., March 13, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an [...]
Indiva Diversifying to Excel in Red Hot Extracts Market -- CFN Media
13/03/2019
SEATTLE, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Conatus Late-breaker Oral Presentation at EASL Meeting to Detail Results of ENCORE-PH Phase 2b Clinical Trial in Patients with NASH Cirrhosis and Severe Portal Hypertension
13/03/2019
SAN DIEGO, March 13, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the acceptance of an abstract for a late-breaker oral presentation at The International Liver Congress™ 2019, the [...]
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Acer Therapeutics to Participate in Upcoming Investor Conferences
13/03/2019
NEWTON, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
13/03/2019
LAVAL, Quebec, March 13, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Vaccinex, Inc. to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 19, 2019
13/03/2019
ROCHESTER, N.Y., March 13, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today [...]
The 3D designed Conformis Hip System Announced at the 2019 AAOS conference
13/03/2019
Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced, patient conforming hip replacement system available BILLERICA, Mass., March 13, [...]
Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101
13/03/2019
U.S. and European patent protections through at least August 2034 NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology [...]

Pages